Quick read · 2 min

Decongestants Don't Touch Your Allergy

Why clearing your nose isn't the same as treating the cause

By Haelo

In short

Why clearing your nose isn't the same as treating the cause

That blocked feeling lifts within minutes of a decongestant spray — so it's easy to assume you're treating your hayfever. You're not. You're treating a side-effect of it.

Here's what's actually happening. When pollen triggers an allergic reaction, your immune system floods the nasal lining with inflammatory signals. Blood vessels swell, tissue puffs up, and the passage narrows. Decongestants — whether pseudoephedrine tablets or an oxymetazoline spray — work by squeezing those blood vessels shut. The swelling drops, you can breathe again. But histamine is still circulating, H1 receptors are still being activated, and the allergic inflammation driving the whole process is completely untouched. The moment the drug wears off, the reaction picks up where it left off.

There's a more immediate problem with nasal sprays specifically. Use one for more than about five days in a row and the vessels can become dependent on the drug to stay narrow. Remove it and they rebound — wider than before, leaving you more congested than when you started. This is rhinitis medicamentosa, and it's a surprisingly easy trap to fall into mid-season.

Decongestants do have a narrow, legitimate use: a flight with a head cold, a single high-stakes presentation. Short-term, occasional, specific.

For an actual season, the evidence points clearly elsewhere. Non-sedating oral antihistamines block the histamine response at source. Intranasal corticosteroid sprays go further — multiple systematic reviews, including a 2024 meta-analysis of 35 randomised trials, show they outperform antihistamines alone on nasal symptoms and quality of life. Used together, the two approaches cover both the fast histamine spike and the slower inflammatory wave that follows.

If you're reaching for a decongestant every morning, it's worth asking whether you're managing your season or just pausing it.

Terms in this article

H1 receptor
A docking site on the surface of nose, eye and skin cells where histamine binds to trigger allergy symptoms.Antihistamines work by occupying these docks before histamine arrives — which is why timing matters.

The evidence

What the research actually says

Each answer below is drawn from a graded research review. Confidence reflects the strength of the underlying evidence, not how confident we feel about it.

Are intranasal steroids more effective than antihistamines?

Intranasal corticosteroids (INS) are consistently more effective than oral antihistamines for treating allergic rhinitis, particularly for nasal symptoms including congestion, rhinorrhea, sneezing, and nasal itching, as demonstrated across multiple systematic reviews and meta-analyses spanning 1998–2024. The 2024 Torres et al. meta-analysis of 35 RCTs found INS superior on Total Nasal Symptom Score (SMD -0.70) and quality of life measures (RQLQ mean difference -0.90) compared to oral antihistamines. Notably, ocular symptoms represent an exception where oral antihistamines perform comparably to INS, and intranasal antihistamines combined with INS outperform oral antihistamines combined with INS.

How it works

Intranasal corticosteroids act through direct topical anti-inflammatory effects on nasal mucosa, suppressing multiple inflammatory mediators (histamine, leukotrienes, cytokines) and reducing both early and late-phase allergic responses, thereby addressing the underlying mucosal inflammation rather than individual symptom pathways. Oral antihistamines selectively block H1-receptor mediated symptoms systemically but achieve limited local nasal concentrations and do not effectively counteract non-histamine inflammatory mediators, explaining their inferior efficacy for congestion in particular.

Confidence: high

Can antihistamines be safely combined with intranasal corticosteroids?

Multiple systematic reviews and meta-analyses consistently demonstrate that combining antihistamines (particularly intranasal formulations) with intranasal corticosteroids is both safe and more effective than either monotherapy alone for allergic rhinitis, with fixed-combination azelastine-fluticasone showing the greatest improvements in total nasal and ocular symptom scores and quality-of-life measures. A 2024 network meta-analysis of 151 RCTs (Sousa-Pinto et al.) confirmed superior efficacy of the fixed combination, especially in seasonal allergic rhinitis, and ARIA 2020 guidelines endorse this approach for moderate-to-severe disease. No significant additional safety signals or drug interactions have been identified beyond those associated with individual agents.

How it works

Intranasal corticosteroids suppress the underlying eosinophilic and inflammatory cascade (reducing cytokine release, mast cell activation, and mucosal edema) via glucocorticoid receptor-mediated gene regulation, while antihistamines competitively block H1 receptors to provide rapid relief of histamine-mediated symptoms such as sneezing, pruritus, and rhinorrhea. This complementary dual-pathway inhibition addresses both the early-phase histamine response and the late-phase inflammatory response, producing additive symptomatic benefit.

Confidence: high

This article is general information about hayfever, not medical advice. It should not replace guidance from your GP, pharmacist or allergy specialist — particularly if you are pregnant, treating a child, or managing asthma alongside hayfever. Read our medical disclaimer.

Reading about it is one thing. Knowing your own season is another.

Haelo turns research like this into what to do today — based on your air, your patterns and your symptoms. Join the waitlist.

No spam. Unsubscribe any time. We'll only contact you about Haelo.